Access the full text.
Sign up today, get DeepDyve free for 14 days.
Ashish Jha, E. Orav, Zhonghe Li, Arnold Epstein (2007)
The inverse relationship between mortality rates and performance in the Hospital Quality Alliance measures.Health affairs, 26 4
W. Janni, M. Kiechle, H. Sommer, B. Rack, K. Gauger, M. Heinrigs, D. Steinfeld, D. Augustin, W. Simon, N. Harbeck, K. Friese (2006)
Study participation improves treatment strategies and individual patient care in participating centers.Anticancer research, 26 5B
(2007)
Identifying high-quality hospitals
S. Zeger, K. Liang (1986)
Longitudinal data analysis for discrete and continuous outcomes.Biometrics, 42 1
Eric Peterson, M. Roe, Jyotsna Mulgund, Elizabeth Delong, B. Lytle, R. Brindis, Sidney Smith, Charles Pollack, Ma Newby, Robert Harrington, W. Gibler, E. Ohman, Ohman, Mss Mulgund, Lytle Kaiser-Permanente, Health System, San Francisco, Philadelphia Pennsylvania, Eric Corresponding, Peterson (2006)
Association between hospital process performance and outcomes among patients with acute coronary syndromes.JAMA, 295 16
(1990)
The case of GISSI in changing the attitudes of Italian cardiologists
Sean O'Brien, E. Peterson (2007)
Identifying high-quality hospitals: consult the ratings or flip a coin?Archives of internal medicine, 167 13
C. Stiller (1994)
Centralised treatment, entry to trials and survival.British Journal of Cancer, 70
P. Romano (2005)
Improving the quality of hospital care in America.The New England journal of medicine, 353 3
D. Braunholtz, Sarah Edwards, R. Lilford (2001)
Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".Journal of clinical epidemiology, 54 3
R. Prescott, C. Counsell, W. Gillespie, A. Grant, I. Russell, S. Kiauka, Colthart Ir, S. Ross, Shepherd Sm, D. Russell (1999)
Factors that limit the quality, number and progress of randomised controlled trials.Health technology assessment, 3 20
S. Majumdar, Wei-Ching Chang, P. Armstrong (2002)
Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?The American journal of medicine, 113 2
(2001)
ESMattera JARoumanis SARadford MJKrumholz HM A qualitative study of increasing β-blocker use after myocardial infarction: why do some hospitals succeed? JAMA 2001;285
Manesh Patel, A. Chen, M. Roe, E. Ohman, L. Newby, Robert Harrington, Sydney Smith, W. Gibler, James Calvin, Eric Peterson (2007)
A comparison of acute coronary syndrome care at academic and nonacademic hospitals.The American journal of medicine, 120 1
A. Bois, Justine Rochon, C. Lamparter, J. Pfisterer (2004)
Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancerInternational Journal of Gynecologic Cancer, 15
E. Bradley, E. Holmboe, J. Mattera, S. Roumanis, M. Radford, H. Krumholz (2001)
A Qualitative Study of Increasing β-Blocker Use After Myocardial Infarction: Why Do Some Hospitals Succeed?JAMA, 285
D. Kandzari, M. Roe, A. Chen, B. Lytle, C. Pollack, R. Harrington, E. Ohman, W. Gibler, E. Peterson (2005)
Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.American heart journal, 149 3
G. Tognoni, M. Franzosi, S. Garattini, A. Maggioni, A. Lotto, F. Mauri, F. Rovelli (1990)
The case of GISSI in changing the attitudes and practice of Italian cardiologists.Statistics in medicine, 9 1-2
ORIGINAL INVESTIGATION Better Outcomes for Patients Treated at Hospitals That Participate in Clinical Trials Sumit R. Majumdar, MD, MPH; Matthew T. Roe, MD, MHS; Eric D. Peterson, MD, MPH; Anita Y. Chen, MS; W. Brian Gibler, MD; Paul W. Armstrong, MD Background: Barriers to institutions participating in increased with increasing tertiles of trial participation: clinical trials include concerns about harms and costs. 76.9% (IQR, 71.8%-81.3%) vs 78.3% (IQR, 73.2%- However, we hypothesized that patients treated at hos- 82.4%) vs 81.1% (IQR, 76.2%-84.1%) (adjusted P = .008). pitals participating in trials would have better outcomes Hospitals that participated in trials had higher adjusted than patients treated at nonparticipating hospitals. We guideline adherence than nonparticipating hospitals (low tested this hypothesis in 494 CRUSADE (Can Rapid Risk enrollment, 0.8% greater [95% confidence interval {CI}, Stratification of Unstable Angina Patients Suppress Ad- −0.9% to 2.6%]; and high enrollment, 2.5% greater [95% verse Outcomes With Early Implementation of the Ameri- CI, 0.5%-4.5%]). In-hospital mortality decreased with in- can College of Cardiology/American Heart Association creasing trial participation: 5.9% vs 4.4% vs 3.5% (ad- Guidelines) hospitals treating 174 062 patients with non– justed P = .003). Patients treated at hospitals that partici- ST-segment elevation acute coronary
JAMA Internal Medicine – American Medical Association
Published: Mar 24, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.